News

BlackDoctor.org1d
Game-Changing Cancer Breakthroughs Could Improve Health Outcomes for Black Communities
New hope is on the horizon in the fight against cancer. At this year’s American Society of Clinical Oncology (ASCO) annual ...
NBC Los Angeles1d
Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO
Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...
BioSpace2d
Rare Disease, Cell and Gene Therapy at Risk From Trump Tariffs, Industry Says
In comments posted in response to the Trump administration’s pharma tariff investigation, companies and industry groups ...
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...
Hutchmed reports progress in late-stage lung cancer trial
(Alliance News) - Hutchmed China Ltd on Monday said its combination therapy for a specific form of advanced lung cancer significantly delayed disease progression compared to chemotherapy, based on ...
Le Lézard4d
Introducing Tempus One in the EHR with Integrated Guidelines
Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the expansion of Tempus One?its generative AI clinical assistant?with ...
Le Lézard6d
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
Danaher Corporation ("Danaher"), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel ...